European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Training next level scientists and researchers to develop highly selective and safe insecticides

Descripción del proyecto

Hacia la obtención de insecticidas de riesgo bajo

Los insecticidas son sustancias que ayudan a eliminar insectos y ácaros que causan enfermedades humanas como la malaria. Aunque su uso tiene ventajas, también puede suponer una grave amenaza tanto para la fauna como para los seres humanos, por ejemplo, a través de los residuos tóxicos en los alimentos y el agua. Esta cuestión ha fomentado la investigación para la creación de insecticidas de riesgo bajo. Un ámbito que se ha investigado es el papel de la enzima citocromo P450 (CIP o CYP, por sus siglas en inglés) en la sensibilidad a los insecticidas. En el proyecto CypTox, financiado con fondos europeos, se analizará la vía metabólica/destoxificación del CIP de los organismos objetivo y no objetivo para obtener insecticidas altamente selectivos y seguros. El trabajo del proyecto también dará lugar a plataformas biotecnológicas de última generación.

Objetivo

Some of the most acute challenges that the world faces are caused by insects and mites that seriously threaten human health and food security. Their control is primarily achieved by the use of insecticides: e.g. malaria prevalence has halved since 2000, saving 660 million lives, with 80% of the reduction being attributable to the use of insecticides. However, both limited availability of low risk insecticides (“insecticides that only fight the bad bugs’) and insecticide resistance represent major threats. So, there is an urgent need to develop novel, safe insecticides. Earlier research pointed to a discriminatory role for the enzyme cytochrome P450 (CYP) in the sensitivity to insecticides. CypTox will exploit the CYP metabolic/detoxification pathway of target and non-target organisms, to develop insecticides, efficient against selected insect & mite major pests and vectors, but highly selective and safe for mammals, pollinators and the environment. Outcomes will also include significantly beyond the state of the art biotechnology platforms (high-throughput cell/enzyme- screening assays and in silico pipelines), that will advance research capabilities for future developments of low risk insecticides. CypTox will provide excellent research training within a creative and flexible environment that actively promotes the integration of academic rigor and commercial pragmatism through mobility between sectors and focused training events. The size and balance of a highly motivated consortium (6 AC/6 industrial–of which 3 SME & 3 TC; 300 well distributed secondments), the involvement of experienced PIs in Horizon2020 and ERC projects and the modern communication, dissemination and exploitation approaches will ensure efficient implementation and impact, at several levels. Enhanced career perspectives for scientists and researchers will be achieved by building a sustainable multidisciplinary and inter-sectoral network, integrating world leading researchers and stakeholders.

Coordinador

IDRYMA TECHNOLOGIAS KAI EREVNAS
Aportación neta de la UEn
€ 464 600,00
Dirección
N PLASTIRA STR 100
70013 Irakleio
Grecia

Ver en el mapa

Región
Νησιά Αιγαίου Κρήτη Ηράκλειο
Tipo de actividad
Research Organisations
Enlaces
Coste total
€ 464 600,00

Participantes (14)

Socios (3)